Biocom Educational Session

Transformative Screening Platforms for Today’s Drug Discovery

June 20th, 8-10 AM, 2018

Venue: Biocom McGraw Boardroom- 10996 Torreyana Rd. Suite 200, San Diego, CA

Registration: https://www.biocom.org/s/EventDetail?event=June-CRO-Event

 

Do you wish to keep abreast of the new developments in cutting-edge screening technologies? Are you trying to rise to the challenge of working with “undruggable” targets? If so, come join us at the next Biocom CRO Educational Session on June 20th. This program will showcase some of the most advanced technologies to help address the challenges that scientists are facing today when low hanging fruits in drug discovery are harder to find. Three featured speakers from Viva Biotech, Takeda Pharmaceuticals and Asellus Therapeutics will be sharing with the audience their know-how and insights from different perspectives. Case studies using different approaches will also be demonstrated. We look forward to a great discussion with all of you who are passionate about technology innovation and drug discovery.

Agenda

8:00AM     Introduction Yinghong Gao, Executive Director, Business Development, Viva biotech

8:15AM     ASMS Screening as an Enabling Platform for Early Lead DiscoveryDr. Shawn Cheng, CTO of Viva Biotech

8:45AM     Takeda’s Tool Kit of Biophysical Methods – Dr. Elisa Barile, Senior Scientist, Takeda Pharmaceuticals

9:15AM     Humanized 3D Modeling for Oncology Drug DiscoveryDr. Brett Hall, CEO of Asellus Therapeutics

9:45AM     Q&A

 

Shawn Cheng, PhD
Shawn Cheng, PhDCTO, Viva Biotech Therapeutics
Elisa Barile, PhD
Elisa Barile, PhDSenior Scientist, Takeda
Brett Hall, PhD
Brett Hall, PhDCEO, Asellus